Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis

Condition:   Transcatheter Aortic Valve Implantation Intervention:   Device: (ALLEGRA Plus Transcatheter Heart Valve) TAVI in severe calcified aortic stenosis or in failed surgical aortic bioprosthesis Sponsor:   NVT GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials